BBOT 8-K: Executive departure
Filed with the SEC on · accession 0001193125-26-449722
BBOT filed a 8-K (current report) with the SEC on Nov 5, 2026. Yong Ben, M.D., M.B.A., Chief Medical and Development Officer of BridgeBio Oncology Therapeutics, provided notice of his resignation effective January 8, 2027.
Summary of the filing
Yong Ben, M.D., M.B.A., Chief Medical and Development Officer of BridgeBio Oncology Therapeutics, provided notice of his resignation effective January 8, 2027. The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.
Key details
✦ Ask GOAX AI about this filing — what it means for BBOT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BBOT?
Click hereFrequently asked questions
What did BBOT file with the SEC on Nov 5, 2026?
BBOT filed a 8-K (Executive departure). Yong Ben, M.D., M.B.A., Chief Medical and Development Officer of BridgeBio Oncology Therapeutics, provided notice of his resignation effective January 8, 2027. The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.
What does a executive departure mean for BBOT stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other BBOT SEC filings
- EFFECT · SEC filingSep 10, 2026
- 8-K · SEC filingSep 8, 2026
- S-3 · Shelf registrationSep 1, 2026
- 424B3 · Secondary offeringAug 12, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · Board changeJun 22, 2026
- 424B3 · Board changeJun 22, 2026
- 424B3 · Secondary offeringMay 13, 2026
- 10-Q · SEC filingMay 12, 2026
Get alerts when BBOT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days